Marker Therapeutics (MRKR) Assets (2010 - 2026)
Marker Therapeutics (MRKR) reported Assets of $14.59 million for Q2 2026, down 1.2% from $14.77 million a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Marker Therapeutics posted Assets of $19.07 million, down 13.4% from FY2024.
- Assets has a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Assets came in at $22.02 million in FY2024 (+28.6%), $17.13 million in FY2023 (-50.2%), $34.42 million in FY2022 (-49.5%) and $68.14 million in FY2021 (+49.4%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q3 2024.
- Year over year, Assets gained in five of the last eight quarters, with growth averaging 14.9%.
- The high point for year-over-year Assets in five years was Q3 2025 (growth of 99.2%); the low point was Q2 2023 (a decline of 58.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.43 million (Q1 2026), $19.07 million (Q4 2025) and $21.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Marker Therapeutics | 20.86 Mn | -39.04 Mn | - | 14.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.59 Mn |
| Mar 31, 2026 | 17.43 Mn |
| Dec 31, 2025 | 19.07 Mn |
| Sep 30, 2025 | 21.73 Mn |
| Jun 30, 2025 | 14.77 Mn |
| Mar 31, 2025 | 16.99 Mn |
| Dec 31, 2024 | 22.02 Mn |
| Sep 30, 2024 | 10.91 Mn |
| Jun 30, 2024 | 11.68 Mn |
| Mar 31, 2024 | 14.09 Mn |
| Dec 31, 2023 | 17.13 Mn |
| Sep 30, 2023 | 19.49 Mn |
| Jun 30, 2023 | 21.96 Mn |
| Mar 31, 2023 | 27.94 Mn |
| Dec 31, 2022 | 34.42 Mn |
| Sep 30, 2022 | 41.11 Mn |
| Jun 30, 2022 | 52.32 Mn |
| Mar 31, 2022 | 54.96 Mn |
| Dec 31, 2021 | 68.14 Mn |
| Sep 30, 2021 | 71.94 Mn |
API Access
Marker Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();